VanEck Associates’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
NAMI
VanEck Associates's OMCL Position: Q2 2026 in Review
VanEck Associates sold out of Omnicell (OMCL) in Q2 2026, closing a stake of 1,980 shares — an estimated $66K sold.
VanEck Associates first reported a position in OMCL in Q3 2022 and held it in 15 quarters. The position peaked at $104K in Q4 2025. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.
- VanEck Associates reported no remaining Omnicell position as of Q2 2026 after selling out during the quarter.
- VanEck Associates sold 1,980 Omnicell shares in Q2 2026, an estimated $66K.
- VanEck Associates first reported a position in Omnicell in Q3 2022 and held it in 15 quarters.
- VanEck Associates's Omnicell position peaked at $104K in Q4 2025.
- 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.